|
Cvs Health Corporation (CVS) |
|
|
|
| |
Cvs Health Income Statement Quarterly
CVS
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Mar 31 2021)
I. Quarter |
(Dec 31 2020)
IV. Quarter |
(Sep 30 2020)
III. Quarter |
(Jun 30 2020)
II. Quarter |
(Mar 31 2020)
I. Quarter |
| Premiums Earned, Net |
18,960.00 |
|
17,182.00 |
16,927.00 |
17,640.00 |
| Revenue From Contract With Customer Excluding Assessed Tax |
47,387.00 |
|
47,738.00 |
46,355.00 |
47,003.00 |
| Other Revenue |
2,750.00 |
|
2,136.00 |
2,059.00 |
2,112.00 |
| Total Revenue |
69,097.00 |
69,554.00 |
67,056.00 |
65,341.00 |
66,755.00 |
| Cost of Goods and Services Sold |
40,894.00 |
42,452.00 |
40,940.00 |
40,242.00 |
40,347.00 |
| Policyholder Benefits and Claims Incurred, Net, Health |
15,704.00 |
15,145.00 |
14,396.00 |
11,751.00 |
14,387.00 |
| Gross
Profit |
12,499.00 |
11,957.00 |
11,720.00 |
13,348.00 |
12,021.00 |
| Selling, Administration, Marketing |
- |
- |
- |
- |
- |
| Depriciation & Amortization |
- |
- |
- |
- |
- |
| Research & development |
- |
- |
- |
- |
- |
| Restructuring charges |
- |
- |
- |
- |
- |
| Other operatinig exp. /-income |
8,922.00 |
-25,702.00 |
8,471.00 |
8,668.00 |
8,563.00 |
| Share based plans expense |
- |
- |
- |
- |
- |
| Operating Expenses Excluding Goodwill Impairments |
- |
35,135.00 |
- |
- |
- |
| Total operating costs including COS |
65,520.00 |
67,030.00 |
63,807.00 |
60,661.00 |
63,297.00 |
| Operating income/-loss
|
3,577.00 |
2,524.00 |
3,249.00 |
4,680.00 |
3,458.00 |
|
Other Deductions / - Income |
| Interest expense |
657.00 |
678.00 |
731.00 |
765.00 |
733.00 |
| Interest income |
- |
- |
- |
- |
- |
| Net interest expense/-income |
657.00 |
678.00 |
731.00 |
765.00 |
733.00 |
| Extinguishment of Debt |
- |
-2,206.00 |
766.00 |
- |
- |
| Net Investment Income |
-297.00 |
-940.00 |
204.00 |
-184.00 |
-162.00 |
| Income from affiliates |
- |
- |
- |
- |
- |
| Depreciation |
- |
- |
- |
- |
- |
| Financing Loss/ -Income |
- |
- |
- |
- |
- |
| Other loss/ -income |
247.00 |
3,767.00 |
-258.00 |
139.00 |
108.00 |
| Total costs & expenses |
66,127.00 |
68,329.00 |
65,250.00 |
61,381.00 |
63,976.00 |
| Income /-loss before income taxes |
2,970.00 |
1,225.00 |
1,806.00 |
3,960.00 |
2,779.00 |
| Income taxes expenses/-benefit |
746.00 |
241.00 |
587.00 |
974.00 |
767.00 |
| Income after income taxes |
2,224.00 |
984.00 |
1,219.00 |
2,986.00 |
2,012.00 |
| Net income/-loss
of other equity |
- |
- |
- |
- |
- |
| Income/-loss
from cont. Ops. |
2,224.00 |
984.00 |
1,219.00 |
2,986.00 |
2,012.00 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
-9.00 |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
2,224.00 |
975.00 |
1,219.00 |
2,986.00 |
2,012.00 |
| Noncontrolling interests |
-1.00 |
-2.00 |
5.00 |
-11.00 |
-5.00 |
| Prefered dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
- |
- |
- |
| Income/-loss to shareholder |
2,223.00 |
973.00 |
1,224.00 |
2,975.00 |
2,007.00 |
| EBIT |
3,627.00 |
1,903.00 |
2,537.00 |
4,725.00 |
3,512.00 |
| EBITD |
4,753.00 |
3,042.00 |
3,651.00 |
5,827.00 |
4,598.00 |
| EBITDA |
4,753.00 |
3,042.00 |
3,651.00 |
5,827.00 |
4,598.00 |
| Per
Share (GAAP Quarterly, in $) |
(Mar 31 2021)
I. Quarter |
(Dec 31 2020)
IV. Quarter |
(Sep 30 2020)
III. Quarter |
(Jun 30 2020)
II. Quarter |
(Mar 31 2020)
I. Quarter |
| Basic EPS (excl. extra
items) |
1.69 |
0.74 |
0.93 |
2.27 |
1.54 |
| Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic Net EPS |
1.69 |
0.74 |
0.93 |
2.27 |
1.54 |
| Basic shares outstanding (Mill.
of Units) |
1,313.00 |
1,311.00 |
1,310.00 |
1,309.00 |
1,306.00 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
1.68 |
0.74 |
0.93 |
2.26 |
1.53 |
| Diluted average shares (Mill.
of Units) |
1,322.00 |
1,315.00 |
1,315.00 |
1,314.00 |
1,312.00 |
| Dividend per share |
0.5 |
0.5 |
0.5 |
0.5 |
0.5 |
|
|
